Rennie PS - Search Results

1

Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model.

Sato N, Gleave ME, Bruchovsky N, Rennie PS, Goldenberg SL, Lange PH, Sullivan LD. Sato N, et al. Among authors: rennie ps. J Steroid Biochem Mol Biol. 1996 May;58(2):139-46. doi: 10.1016/0960-0760(96)00018-0. J Steroid Biochem Mol Biol. 1996. PMID: 8809195

2

Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genes.

Rennie PS, Bruchovsky N, Coldman AJ. Rennie PS, et al. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):843-7. doi: 10.1016/0960-0760(90)90430-s. J Steroid Biochem Mol Biol. 1990. PMID: 2126735

3

Relationship of androgen receptors to the growth and regression of the prostate.

Rennie PS, Bruchovsky N, Goldenberg SL. Rennie PS, et al. Am J Clin Oncol. 1988;11 Suppl 2:S13-7. doi: 10.1097/00000421-198801102-00004. Am J Clin Oncol. 1988. PMID: 3071950 Review.

4

[Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma].

Bruchovsky N, Goldenberg SL, Rennie PS, Gleave M. Bruchovsky N, et al. Among authors: rennie ps. Urologe A. 1995 Sep;34(5):389-92. Urologe A. 1995. PMID: 7483155 Review. German.

5

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.

Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, Sullivan LD. Akakura K, et al. Among authors: rennie ps. Cancer. 1993 May 1;71(9):2782-90. doi: 10.1002/1097-0142(19930501)71:9<2782::aid-cncr2820710916>3.0.co;2-z. Cancer. 1993. PMID: 7682149

6

Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol.

Bruchovsky N, Goldenberg SL, Akakura K, Rennie PS. Bruchovsky N, et al. Among authors: rennie ps. Cancer. 1993 Sep 1;72(5):1685-91. doi: 10.1002/1097-0142(19930901)72:5<1685::aid-cncr2820720532>3.0.co;2-3. Cancer. 1993. PMID: 7688656 Clinical Trial.

7

Effect of tumour progression on the androgenic regulation of the androgen receptor, TRPM-2 and YPT1 genes in the Shionogi carcinoma.

Rennie PS, Bruchovsky N, Akakura K, Goldenberg SL, Otal N, Akakura S, Wong P, Tenniswood M. Rennie PS, et al. J Steroid Biochem Mol Biol. 1994 Jul;50(1-2):31-40. doi: 10.1016/0960-0760(94)90169-4. J Steroid Biochem Mol Biol. 1994. PMID: 8049130

8

Control of tumor progression by maintenance of apoptosis.

Bruchovsky N, Snoek R, Rennie PS, Akakura K, Goldenberg LS, Gleave M. Bruchovsky N, et al. Among authors: rennie ps. Prostate Suppl. 1996;6:13-21. Prostate Suppl. 1996. PMID: 8630223 Review.

9

[Hormone release and intermittent hormonal therapy in the LN CaP model of human prostate cancer].

Gleave M, Santo N, Rennie PS, Goldenberg SL, Bruchovsky N, Sullivan LD. Gleave M, et al. Among authors: rennie ps. Prog Urol. 1996 Jun;6(3):375-85. Prog Urol. 1996. PMID: 8763692 French.

10

Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides.

Snoek R, Rennie PS, Kasper S, Matusik RJ, Bruchovsky N. Snoek R, et al. Among authors: rennie ps. J Steroid Biochem Mol Biol. 1996 Nov;59(3-4):243-50. doi: 10.1016/s0960-0760(96)00116-1. J Steroid Biochem Mol Biol. 1996. PMID: 9010316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters